307 related articles for article (PubMed ID: 24127605)
1. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.
Wood JP; Bunce MW; Maroney SA; Tracy PB; Camire RM; Mast AE
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17838-43. PubMed ID: 24127605
[TBL] [Abstract][Full Text] [Related]
2. Biology of tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Blood; 2014 May; 123(19):2934-43. PubMed ID: 24620349
[TBL] [Abstract][Full Text] [Related]
3. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
[TBL] [Abstract][Full Text] [Related]
4. New insights into the biology of tissue factor pathway inhibitor.
Maroney SA; Mast AE
J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S200-7. PubMed ID: 26149025
[TBL] [Abstract][Full Text] [Related]
5. TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.
Wood JP; Petersen HH; Yu B; Wu X; Hilden I; Mast AE
Blood Adv; 2017 Dec; 1(27):2692-2702. PubMed ID: 29291252
[TBL] [Abstract][Full Text] [Related]
6. The C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg
van Doorn P; Rosing J; Wielders SJ; Hackeng TM; Castoldi E
J Thromb Haemost; 2017 Jan; 15(1):140-149. PubMed ID: 27801970
[TBL] [Abstract][Full Text] [Related]
7. Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.
Mast AE; Ruf W
J Thromb Haemost; 2022 Jun; 20(6):1290-1300. PubMed ID: 35279938
[TBL] [Abstract][Full Text] [Related]
8. Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.
Petrillo T; Ayombil F; Van't Veer C; Camire RM
J Biol Chem; 2021; 296():100234. PubMed ID: 33376137
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
Dahlbäck B
J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
[TBL] [Abstract][Full Text] [Related]
10. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
[TBL] [Abstract][Full Text] [Related]
11. Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα.
van Doorn P; Rosing J; Campello E; Middeldorp S; Simioni P; Meijers JCM; Hackeng TM; Castoldi E
Thromb Haemost; 2020 Jan; 120(1):55-64. PubMed ID: 31705518
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
[TBL] [Abstract][Full Text] [Related]
13. Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
Mast AE
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):9-14. PubMed ID: 26603155
[TBL] [Abstract][Full Text] [Related]
14. Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.
Maroney SA; Hansen KG; Mast AE
Curr Opin Hematol; 2013 Sep; 20(5):403-9. PubMed ID: 23839295
[TBL] [Abstract][Full Text] [Related]
15. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.
Maroney SA; Ellery PE; Wood JP; Ferrel JP; Martinez ND; Mast AE
J Thromb Haemost; 2013 May; 11(5):911-8. PubMed ID: 23480518
[TBL] [Abstract][Full Text] [Related]
18. Platelet tissue factor pathway inhibitor modulates intravascular coagulation.
Maroney SA; Mast AE
Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S21-2. PubMed ID: 22425319
[TBL] [Abstract][Full Text] [Related]
19. Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.
Wood JP; Baumann Kreuziger LM; Ellery PER; Maroney SA; Mast AE
Blood Adv; 2017 Feb; 1(6):386-395. PubMed ID: 28580443
[TBL] [Abstract][Full Text] [Related]
20. Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.
Santamaria S; Reglińska-Matveyev N; Gierula M; Camire RM; Crawley JTB; Lane DA; Ahnström J
J Biol Chem; 2017 Jun; 292(22):9335-9344. PubMed ID: 28420729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
